Nigelle 5 in Prevention of Influanza

Summary

This study will be carried out by more than 30 liberal Tunisian doctors, who will submit according to the inclusion / exclusion criteria of people who will receive (free of charge) a capsule of the Nig5 product sublingually, each day. Against a control group which will be followed with the same protocol as the first but which will not receive the product. Randomization (even days: nigella group, odd days: control group)

Timeline

Start

2021-06-05

Primary completion

2021-07-31

Completion

2021-08-31

Drugs

Indications